BioXcel Therapeutics (BTAI) PT Lowered to $25 at UBS

February 16, 2022 1:59 AM EST Send to a Friend
UBS analyst Colin Bristow lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login